Neuroprotection Considerable interest has been shown in putative neuroprotective actions of lithium, particularly with regards to dementing illnesses, although the epidemiological evidence remains challengeable [Young, 2011]. Several of the previously described mechanisms, independently or synergistically, may be protective of brain cell functioning [Chiu and Chuang 2010]: inhibition of glutamatergic excitotoxicity via NMDA receptor-mediated calcium influx; inhibition of autophagy, including in the presence of the insult of β-amyloid [Alvarez et al. 2002]; increasing neuronal growth cones, via IMPase inhibition and inositol depletion; and induction and upregulation

of the cortical developmental neurotrophins Inhibitors,research,lifescience,medical brain-derived neurotrophic factor (BDNF) [Yasuda et al. 2009] and vascular endothelial growth factor (VEGF) [Guo et al. 2009]. Grey and white matter volume Magnetic resonance imaging

Inhibitors,research,lifescience,medical (MRI) studies have demonstrated increased grey matter volume in bipolar patients, following administration of lithium [Moore et al. 2000b; Sassi et al. 2002; Bearden et al. 2007]. Studies have generally failed to identify any effects in white matter, although Monkul and colleagues found increased dorsolateral prefrontal cortex and cingulate grey matter volume and increased white matter volume in healthy subjects Inhibitors,research,lifescience,medical following lithium administration [Monkul et al. 2007], potentially highlighting the different generalised effects of lithium in healthy and diseased brains. The regional specificity of these findings makes it unlikely

that these findings are due to the osmotic effects of lithium; instead, Inhibitors,research,lifescience,medical the neurotrophic effect of lithium seems a more viable explanation [Moore et al. 2000b; Sassi et al. 2002; Bearden et al. 2007; Monkul et al. 2007]. Notably, lithium’s ability to Inhibitors,research,lifescience,medical robustly increase expression of the cytoprotective protein B-cell lymphoma/leukaemia 2 (bcl-2) [Chen et al. 1999; Manji et al. 2000a; Moore et al. 2000b], as well as its effects on GSK3 [Klein and Melton, PDK4 1996; Stambolic et al. 1996; Chalecka-Franaszek and Chuang, 1999; De Sarno et al. 2002; Beaulieu et al. 2004], is thought to exert major neurotrophic effects, resulting in neuropil increases, increased N-acetyl-aspartate (NAA) levels (a postulated marker of neuronal viability and function), with significant effects on grey matter volume [Manji et al. 2000b; Moore et al. 2000a]. Conclusion: pulling the evidence together Lithium is chemically remarkably simple and, in human neuronal tissue, biochemically remarkably AP24534 in vitro complex. Its clinical efficacy in mood disorders is well established and there is growing epidemiological evidence to support broader effects including positively altering aggression and suicide rates, and potentially being protective against neurodegenerative disorders.